Marketing of unproven stem cell–based interventions: A call to action

Science Translational Medicine
05 July 2017  Vol 9, Issue 397
http://stm.sciencemag.org/

Perspective
Marketing of unproven stem cell–based interventions: A call to action
By Douglas Sipp, Timothy Caulfield, Jane Kaye, Jan Barfoot, Clare Blackburn, Sarah Chan, Michele De Luca, Alastair Kent, Christopher McCabe, Megan Munsie, Margaret Sleeboom-Faulkner, Jeremy Sugarman, Esther van Zimmeren, Amy Zarzeczny, John E. J. Rasko
Science Translational Medicine05 Jul 2017 Restricted Access
Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that should be addressed by coordinated approaches at the national and international levels.